Article
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.
The American journal of gastroenterology - 1 Nov 2000
Fried M W, Shiffman M, Sterling R K, Weinstein J, Crippin J, Garcia G, Wright T L, Conjeevaram H, Reddy K R, Peter J, Cotsonis G A, Nolte F S
Abstract excerpt
OBJECTIVES: The aim of this study was to determine prospectively whether an intensive regimen of daily, high-dose interferon would improve the response rate for the treatment of chronic hepatitis C in patients with unfavorable virological characteristics. METHODS: A total of 104 patients with chr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.